Pharmacelera

About Pharmacelera

Pharmacelera develops proprietary Computer-Aided Drug Design (CADD) software using Quantum-Mechanics algorithms, Machine Learning, and High-Performance Computing (HPC) based on over 25 years of research. Their mission is to enhance pharmaceutical R&D productivity through a lean drug discovery process, focusing on early-stage drug discovery to predict and test candidate molecules with higher success rates. They aim to mine unexploited chemical spaces for greater diversity, enabling new therapies for unmet medical needs.

Products & Services

PharmScreen:A field-based virtual screening software designed to find candidate molecules with larger chemical diversity from proprietary, public, or commercial compound libraries.

exaScreen:Virtual screening software for exploring ultra-large synthesizable chemical libraries with high accuracy, combining AI and Quantum Mechanics to uncover novel and diverse hits.

PharmQSAR:A 3D Quantitative Structure-Activity Relationship (QSAR) software that builds statistical models based on experimental assay data.

Open-Source:Open-source tools or resources provided by Pharmacelera for drug discovery and computational chemistry.

Services:Computational chemistry services for small biotech companies, big pharma R&D departments, public research institutions, and CROs, covering Target-to-Hit, Hit-to-Lead, and Lead Optimization stages with tailored in-silico solutions.

Specialties

Computer-Aided Drug Design (CADD) Quantum Mechanics (QM) Artificial Intelligence (AI) Machine Learning (ML) High-Performance Computing (HPC) Virtual Screening Drug Discovery 3D Molecular Descriptors

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment Round T: - FT: Investment Round	A: 6000000 MR: - FA: €6 million FAN: 6000000	D: 2026-02-18 FD: 2026-02-18	4 investors

Investment Round Latest

2026-02-18

$6.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Enric Gibert

CEO & Co-founder

LinkedIn (Pro only)

J

Javier Luque

Chief Scientific Officer and Co-founder

E

Enric Herrero

CTO & Co-founder

LinkedIn (Pro only)

G

Greta Cánovas

CFO

R

Remy Hoffmann

Chief Business Development Officer

T

Tiziana Ginex

Senior Researcher

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Pharmacelera Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised